Literature DB >> 14993574

Effectiveness and safety of tissue plasminogen activator in the management of complicated parapneumonic effusions.

Michael Weinstein1, Ricardo Restrepo, Peter G Chait, Bairbre Connolly, Michael Temple, Colin Macarthur.   

Abstract

OBJECTIVE: The management of parapneumonic effusions in children is controversial. The objective of this study was to evaluate the effectiveness and safety of intrapleural tissue plasminogen activator (tPA) in children who require tube thoracostomy for drainage of a complicated parapneumonic effusion.
METHODS: An observational cohort study was used to compare children who were treated with intrapleural tPA (either early or late administration) with children who were treated with thoracostomy tube drainage alone.
RESULTS: Over a 6-year period, 12 children received early tPA (within 24 hours of diagnosis), 18 children received late tPA (>24 hours after diagnosis), and 23 children received thoracostomy tube drainage alone for the management of a complicated parapneumonic effusion. Total pleural fluid drainage was highest for the late tPA group (691 mL vs 360 mL in the control group); however, the rate of pleural fluid drainage was highest for the early tPA group (7 mL/h vs 3 mL/h in the control group). The duration of chest tube placement was 84 hours for the early tPA group, 209 hours for the late tPA group, and 130 hours for the control group. There was a significant difference in duration of chest tube placement between the early and late tPA groups. No child who was treated with tPA developed local or systemic bleeding.
CONCLUSIONS: Early administration of intrapleural tPA seems to be a safe and potentially effective treatment in children with complicated parapneumonic effusions. Randomized controlled trial evidence is needed to confirm this finding.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14993574     DOI: 10.1542/peds.113.3.e182

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  8 in total

Review 1.  Use of fibrinolytics in abdominal and pleural collections.

Authors:  Anuradha S Shenoy-Bhangle; Debra A Gervais
Journal:  Semin Intervent Radiol       Date:  2012-12       Impact factor: 1.513

2.  Paediatric complicated pneumonia: Diagnosis and management of empyema.

Authors:  Tk Chibuk; E Cohen; Jl Robinson; S Mahant; Ds Hartfield
Journal:  Paediatr Child Health       Date:  2011-08       Impact factor: 2.253

3.  Stratifying fibrinolytic dosing in pediatric parapneumonic effusion based on ultrasound grade correlation.

Authors:  Charles A James; Leah E Braswell; Amir H Pezeshkmehr; Paula K Roberson; James A Parks; Mary B Moore
Journal:  Pediatr Radiol       Date:  2016-10-05

4.  Intrapleural Fibrinolysis with Urokinase Versus Alteplase in Complicated Parapneumonic Pleural Effusions and Empyemas: A Prospective Randomized Study.

Authors:  Carmen Alemán; José M Porcel; José Alegre; Eva Ruiz; Silvia Bielsa; Jordi Andreu; Maria Deu; Pilar Suñé; Mireia Martínez-Sogués; Iker López; Esther Pallisa; Joan Antoni Schoenenberger; J Bruno Montoro; Tomás Fernández de Sevilla
Journal:  Lung       Date:  2015-09-30       Impact factor: 2.584

5.  Retrospective analysis of large-dose intrapleural alteplase for complicated pediatric parapneumonic effusion and empyema.

Authors:  Jessica L Taylor; Meixia Liu; David S Hoff
Journal:  J Pediatr Pharmacol Ther       Date:  2015 Mar-Apr

6.  Alteplase: pleural effusion (parapneumonic) and empyema in children.

Authors:  Joyce A Generali; Dennis J Cada
Journal:  Hosp Pharm       Date:  2013-12

7.  Intrapleural hemorrhage due to alteplase use in a 6-year-old boy with pleural effusion.

Authors:  Mohamed A Hendaus; Ahmad Abushahin
Journal:  Int J Gen Med       Date:  2013-04-12

Review 8.  Pneumonia in hospitalized children.

Authors:  Thomas J Sandora; Marvin B Harper
Journal:  Pediatr Clin North Am       Date:  2005-08       Impact factor: 3.278

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.